Q4 2022 Earnings

Investor Relations

Press Releases

10 Oct '24
NLP-enhanced data from over 154 million patient records facilitates innovation in real-world evidence research via the Veradigm Network CHICAGO --(BUSINESS WIRE)--Oct. 10, 2024-- Veradigm ® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, announced today the complete

Stock Information

Minimum 15 minutes delayed. Source: LSEG

Contact Investor Relations

Jenny Gelinas
Vice President, Investor Relations
jenny.gelinas@veradigm.com